CNX-2006 |
|
B3227-25 |
ApexBio |
25 mg |
EUR 517.2 |
|
Description: CNX-2006, a structural analog of CO-1686, is a selective and irreversible inhibitor of mutant-EGFR with IC50 value of < 20 nM. |
Human IgG antibody Laboratories manufactures the odn 2006 invivogen reagents distributed by Genprice. The Odn 2006 Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Odn products are available in stock. Specificity: Odn Category: 2006 Group: Invivogen
ODN 2006-Type B (human) |
|
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
Invivogen information
ODN 2336-Type A (human) |
|
VAdv-Ly0065-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2216-Type A (human) |
|
VAdv-Ly0066-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
|
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2216-Type A (human) |
|
VAdv-Ly0066-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 1668-Type B (murine) |
|
VAdv-Ly0067-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
|
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 1668-Type B (murine) |
|
VAdv-Ly0067-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN INH-47-Class R (restricted) inhibitory ODN TLR9 Antagonist-Palindromic variant of ODN INH-1-antigen grade |
|
ODNINH47-1 |
Alpha Diagnostics |
200 ug |
EUR 270 |
Neutral ODN control ODN without agonistic nor antagonistic activity antigen grade |
|
ODN-NT-1 |
Alpha Diagnostics |
100 ug |
EUR 781.2 |
ODN INH-18 class R (?restricted?) inhibitory ODN-TLR9 antagonist antigen grade |
|
ODNINH18-1 |
Alpha Diagnostics |
200 µg |
EUR 270 |
CpG ODN, Class A (Murine) |
|
VAdv-Ly0013 |
Creative Biolabs |
1 mg |
EUR 5190 |
|
Description: CpG ODN, murine TLR9 agonist, Oligodeoxy Nucleotide vaccine adjuvant. |
ODN 2395-Type C (human/murine) |
|
VAdv-Ly0064-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
|
Description: ODN 2395-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2395-Type C (human/murine) |
|
VAdv-Ly0064-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 2395-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2007-Type B (Bovine/Porcine) |
|
VAdv-Ly0052-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
|
Description: ODN 2007-Type B, bovine/porcine TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2007-Type B (Bovine/Porcine) |
|
VAdv-Ly0052-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN 2007-Type B, bovine/porcine TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant. |
ODN INH-1-Class R (restricted) inhibitory ODN-TLR 9 Antagonist-antigen grade |
|
ODNINH1-1 |
Alpha Diagnostics |
200 ug |
EUR 270 |
ODN M362-Type C (human/murine) |
|
VAdv-Ly0063-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
|
Description: ODN M362-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN M362-Type C (human/murine) |
|
VAdv-Ly0063-5mg |
Creative Biolabs |
5 mg |
EUR 5322 |
|
Description: ODN M362-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2216-Type A (human, FITC Conjugate) |
|
VAdv-Ly0048 |
Creative Biolabs |
50 µg |
EUR 446.4 |
|
Description: ODN 2216-Type A, human TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant. |
